檢索結果 - Sarah Oelsner

  • Showing 1 - 5 results of 5
Refine Results
  1. 1
    Chimeric Antigen Receptor-Engineered NK-92 Cells: An Off-the-Shelf Cellular Therapeutic for Targeted Elimination of Cancer Cells and Induction of Protective Antitumor Immunity

    Chimeric Antigen Receptor-Engineered NK-92 Cells: An Off-the-Shelf Cellular Therapeutic for Targeted Elimination of Cancer Cells and Induction of Protective Antitumor Immunity 由 Congcong Zhang, Pranav Oberoi, Sarah Oelsner, Anja Waldmann, Aline Lindner, Torsten Tonn, Winfried S. Wels

    出版 2017
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  2. 2
    Dual targeting of glioblastoma with chimeric antigen receptor-engineered natural killer cells overcomes heterogeneity of target antigen expression and enhances antitumor activity and survival

    Dual targeting of glioblastoma with chimeric antigen receptor-engineered natural killer cells overcomes heterogeneity of target antigen expression and enhances antitumor activity a... 由 Sabrina Genßler, Michael C. Burger, Congcong Zhang, Sarah Oelsner, Iris Mildenberger, Marlies Wagner, Jörg Steinbach, Winfried S. Wels

    出版 2015
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  3. 3
    Continuously expanding CAR NK-92 cells display selective cytotoxicity against B-cell leukemia and lymphoma

    Continuously expanding CAR NK-92 cells display selective cytotoxicity against B-cell leukemia and lymphoma 由 Sarah Oelsner, Miriam E. Friede, Congcong Zhang, Juliane Wagner, Susanne Badura, Peter Bader, Evelyn Ullrich, Oliver G. Ottmann, Hans Klingemann, Torsten Tonn, Winfried S. Wels

    出版 2016
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  4. 4
    Genetically engineered CAR NK cells display selective cytotoxicity against FLT3‐positive B‐ALL and inhibit <i>in vivo</i> leukemia growth

    Genetically engineered CAR NK cells display selective cytotoxicity against FLT3‐positive B‐ALL and inhibit <i>in vivo</i> leukemia growth 由 Sarah Oelsner, Anja Waldmann, Arne Billmeier, Jasmin Röder, Aline Lindner, Evelyn Ullrich, Rolf Marschalek, Gianpietro Dotti, Gundram Jung, Ludger Große‐Hovest, Pranav Oberoi, Peter Bader, Winfried S. Wels

    出版 2019
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  5. 5
    Chimeric antigen receptor‐engineered cytokine‐induced killer cells overcome treatment resistance of pre‐B‐cell acute lymphoblastic leukemia and enhance survival

    Chimeric antigen receptor‐engineered cytokine‐induced killer cells overcome treatment resistance of pre‐B‐cell acute lymphoblastic leukemia and enhance survival 由 Sarah Oelsner, Juliane Wagner, Miriam E. Friede, Verena Pfirrmann, Sabrina Genßler, Eva Rettinger, Christian J. Buchholz, Roman Pfeifer, Ralf Schubert, Oliver G. Ottmann, Evelyn Ullrich, Peter Bader, Winfried S. Wels

    出版 2016
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:

檢索工具: